The market for Interstitial Cystitis Drugs is characterized by the increasing number of new drugs being introduced in the market. This condition is a chronic complication of uric acid deficiency. There are several available treatments, which include intravenous, oral, and symptomatic. Interstitial cystitis is a chronic disease that causes discomfort in the lower urinary tract and bladder. It is most prevalent in women and is associated with many comorbidities.
Increasing product launch and drug approvals by regulatory authorities is expected to boost growth of the global interstitial cystitis drugs market during the forecast period. For instance, in September 2020, Red Life Medical Inc. announced the launch of INSTYLAN indicated for the treatment of interstitial cystitis (IC) or Bladder Pain Syndrome (BPS). INSTYLAN is a new brand of Hyaluronic Acid (HA) for instillation of bladder.
However, limitations on the efficiency and compliance of the available products is expected to hamper growth of the global interstitial cystitis drugs market during the forecast period.
𝗕𝘂𝘆-𝗡𝗼𝘄 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗮𝗻𝗱 𝗴𝗲𝘁 𝘂𝗽 𝘁𝗼 𝟴𝟬% 𝗗𝗜𝗦𝗖𝗢𝗨𝗡𝗧
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4488
Impact of COVID-19:
The global interstitial cystitis drugs market witnessed a moderate impact of the COVID-19 pandemic outbreak. Following the outbreak in China caused several countries to close down borders and hold international travel temporarily. Employment of stringent lockdown policies impacted manufacturing activities across several industries. The spread of the virus increased the distress in patients with IC causing psychological symptoms such as boredom, fear, frustration, sadness. A personalized treatment providing a web-mediated counseling for these patients could benefit the relationship-based method of change focusing on improvement in life quality.
The global interstitial cystitis drugs market is expected to expand, exhibiting a CAGR of 6.6 % over the forecast period due to advent of regenerative and gene therapy for the treatment of interstitial cystitis. For instance, a research published in the journal ‘International Neurology’ on September 30, 2020 by scientists from Taiwan, showed that Stem cells therapy combined with Low-energy shock waves (LESW), and platelet-rich plasma (PRP) therapy proved to be effective by improving bladder regeneration, inhibiting bladder inflammation, relieving bladder pain, and increasing capacity of the bladder in some of the preclinical studies.
North America is expected to witness robust growth in the global interstitial cystitis market during the forecast period, owing to increasing prevalence of interstitial cystitis in the region.
Key players active in the global interstitial cystitis drugs market are Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Pfizer Inc., Bayer AG, Sun Pharmaceutical Industries Ltd., Novartis AG, Seikagaku Corp., Eli Lilly and Co., Perrigo Co. Plc, and Mylan NV.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Interstitial Cystitis Drugs Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Interstitial Cystitis Drugs Industry Impact
Chapter 2 Global Interstitial Cystitis Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Interstitial Cystitis Drugs (Volume and Value) by Type
2.3 Global Interstitial Cystitis Drugs (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Interstitial Cystitis Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Interstitial Cystitis Drugs Market Analysis
Chapter 6 East Asia Interstitial Cystitis Drugs Market Analysis
Chapter 7 Europe Interstitial Cystitis Drugs Market Analysis
Chapter 8 South Asia Interstitial Cystitis Drugs Market Analysis
Chapter 9 Southeast Asia Interstitial Cystitis Drugs Market Analysis
Chapter 10 Middle East Interstitial Cystitis Drugs Market Analysis
Chapter 11 Africa Interstitial Cystitis Drugs Market Analysis
Chapter 12 Oceania Interstitial Cystitis Drugs Market Analysis
Chapter 13 South America Interstitial Cystitis Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in Interstitial Cystitis Drugs Business
Chapter 15 Global Interstitial Cystitis Drugs Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027